Research graph
References from Recent Evidences of the Use of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Colorectal Cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Staging and follow-up of gastrointestinal tumors with PET/CT
10.1007/s00261-005-0031-3 · 2006 · External reference
Positron emission tomography: clinical applications in oncology
10.1586/14737140.5.6.1079 · 2005 · External reference
FDG accumulation and tumor biology
10.1016/s0969-8051(97)00226-6 · 1998 · External reference
Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice
1999 · External reference
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
10.1016/s0959-8049(99)00229-4 · 1999 · External reference
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings
10.1148/radiology.206.3.9494497 · 1998 · External reference
Preoperative evaluation by whole-body 18Ffluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer
2000 · External reference
Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making
2003 · External reference
Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer
10.1245/aso.2006.04.042 · 2006 · External reference
Does positron emission tomography change management in primary rectal cancer?
10.1007/s10350-003-0089-3 · 2004 · External reference
Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma
2003 · External reference
Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology
10.1001/jama.290.24.3199 · 2003 · External reference
Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging
10.1200/jco.2005.01.4340 · 2005 · External reference
Cancer statistics, 2006
10.3322/canjclin.56.2.106 · 2006 · External reference
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases
10.1016/s0002-9610(99)00187-7 · 1999 · External reference
The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study
2002 · External reference
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases
10.1002/cncr.21569 · 2005 · External reference
Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
10.1097/01.sla.0000146145.69835.c5 · 2004 · External reference
An audit of fusion CT-PET in the management of colorectal liver metastases
10.1016/j.ejso.2006.02.003 · 2006 · External reference
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer
2005 · External reference
The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases
10.1089/cbr.2005.20.450 · 2005 · External reference
Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases
10.1200/jco.2005.04.4222 · 2005 · External reference
Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
10.1097/00000658-199803000-00001 · 1998 · External reference
False positive F-18 fluorodeoxyglucose combined PET/CT scans from suture granuloma and chronic inflammation: report of two cases and review of literature
10.47102/annals-acadmedsg.v34n7p457 · 2005 · External reference
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography
10.1007/bf02303744 · 1997 · External reference
Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup
10.1067/msy.2001.116919 · 2001 · External reference
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients
10.1016/s1072-7515(03)00337-5 · 2003 · External reference
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum
10.1007/bf02238010 · 2000 · External reference
FDG-PET improves the management of patients with suspected recurrence of colorectal cancer
10.1097/00006231-200210000-00007 · 2002 · External reference
Positron emission tomography affects surgical management in recurrent colorectal cancer patients
10.1245/aso.2003.05.006 · 2003 · External reference
10.1007/s10434-001-0779-9
10.1007/s10434-001-0779-9 · 2001 · External reference
Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection
10.1148/radiol.2323031065 · 2004 · External reference
Preoperative versus postoperative chemoradiotherapy for rectal cancer
10.1056/nejmoa040694 · 2004 · External reference
Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography
10.1007/bf02237238 · 2000 · External reference
Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology
10.1007/s00259-003-1453-1 · 2004 · External reference
Positron emission tomography during preoperative combined modality therapy for rectal cancer may predict ultimate pathologic response
10.1200/jco.2005.23.16_suppl.3612 · 2005 · External reference
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining long term outcomes of rectal cancer
10.1016/j.jamcollsurg.2004.02.024 · 2004 · External reference
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation
10.1016/j.ijrobp.2003.09.058 · 2004 · External reference
